Holen Sie sich die Stockscreener-App
6.62
4.47%
-0.31
Handel nachbörslich:
6.80
0.18
+2.72%
Schlusskurs vom Vortag:
$6.93
Offen:
$6.95
24-Stunden-Volumen:
698.95K
Relative Volume:
1.27
Marktkapitalisierung:
$167.07M
Einnahmen:
$675.00K
Nettoeinkommen (Verlust:
$-26.62M
KGV:
-4.2158
EPS:
-1.5703
Netto-Cashflow:
$-31.34M
1W Leistung:
+8.35%
1M Leistung:
+0.46%
6M Leistung:
+43.91%
1J Leistung:
+1,183%
1-Tages-Spanne:
$6.51
$7.15
1-Wochen-Bereich:
$6.20
$7.44
52-Wochen-Spanne:
$0.45
$8.2457
Unicycive Therapeutics Inc Stock (UNCY) Company Profile
Firmenname
Unicycive Therapeutics Inc
Sektor
Branche
Telefon
650-384-0642
Adresse
4300 EL CAMINO REAL, SUITE 210, LOS ALTOS
Compare UNCY vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
UNCY
Unicycive Therapeutics Inc
|
6.62 | 174.90M | 675.00K | -26.62M | -31.34M | -1.5703 |
VRTX
Vertex Pharmaceuticals Inc
|
434.30 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
763.04 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
748.25 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.34 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.81 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Unicycive Therapeutics Inc Stock (UNCY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-21 | Eingeleitet | Guggenheim | Buy |
| 2024-04-04 | Eingeleitet | Piper Sandler | Overweight |
Unicycive Therapeutics Inc Aktie (UNCY) Neueste Nachrichten
Benchmark cuts Unicycive Therapeutics price target on updated assumptions By Investing.com - Investing.com Canada
Unicycive Therapeutics director Gaurav Aggarwal resigns from board - Investing.com
Unicycive Therapeutics, Inc. Files Form 8-K Announcing Departure and Appointment of Directors and Officers - Minichart
Unicycive Therapeutics (UNCY) director Gaurav Aggarwal steps down from board - stocktitan.net
Gaurav Aggarwal resigns from Unicycive Board - TradingView
Benchmark Cuts Unicycive Therapeutics (NASDAQ:UNCY) Price Target to $15.00 - marketbeat.com
Aug Movers: Should you avoid Unicycive Therapeutics Inc stock right now2026 Sentiment & Risk Managed Investment Entry Signals - baoquankhu1.vn
HC Wainwright Boosts Earnings Outlook for Unicycive Therapeutics - National Today
HC Wainwright Issues Positive Estimate for UNCY Earnings - marketbeat.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Unicycive Therapeutics, Inc. (UNCY) And Encourages Shareholders to Reach Out - ACCESS Newswire
Guggenheim Maintains Unicycive Therapeutics(UNCY.US) With Buy Rating, Cuts Target Price to $40 - Moomoo
Unicycive Therapeutics (UNCY) Target Price Lowered by Guggenheim | UNCY Stock News - GuruFocus
Guggenheim Has Lowered Expectations for Unicycive Therapeutics (NASDAQ:UNCY) Stock Price - marketbeat.com
Noble Financial Has Positive Forecast for UNCY Q1 Earnings - marketbeat.com
UNCY Stock Price, Quote & Chart | UNICYCIVE THERAPEUTICS INC (NASDAQ:UNCY) - ChartMill
UNCY SEC FilingsUnicycive Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
H.C. Wainwright Sticks to Their Buy Rating for Unicycive Therapeutics (UNCY) - The Globe and Mail
Noble Financial Brokers Boost Earnings Estimates for UNCY - marketbeat.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Unicycive Therapeutics, Inc. (UNCY) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Noble Financial Maintains Unicycive Therapeutics(UNCY.US) With Buy Rating, Maintains Target Price $60 - Moomoo
Unicycive Therapeutics | 10-K: FY2025 Annual Report - Moomoo
Unicycive Therapeutics, Inc. (UNCY) Reports FY2025 Earnings - AlphaStreet
USA Rare Earth, Inc. (USAR) Reports Q4 Earnings - AlphaStreet
Unicycive Therapeutics Reports 2025 Financial Results; OLC NDA Under FDA Review with Potential Approval in June 2026 - Minichart
Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update - National Today
Unicycive Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Unicycive Therapeutics (NASDAQ:UNCY) Releases Quarterly Earnings Results, Misses Estimates By $0.36 EPS - MarketBeat
Unicycive (UNCY) narrows 2025 loss, FDA accepts kidney drug NDA resubmission - stocktitan.net
Unicycive Therapeutics : March 2026 Corporate Presentation - marketscreener.com
Unicycive Therapeutics 10-K: Net loss $26.6M, EPS $(1.67) - TradingView
Unicycive (NASDAQ: UNCY) advances OLC NDA toward June 2026 PDUFA as UNI-494 is paused - stocktitan.net
Bronstein, Gewirtz & Grossman, LLC Encourages Unicycive Therapeutics, Inc. (UNCY) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Published on: 2026-03-28 07:58:35 - baoquankhu1.vn
Published on: 2026-03-27 21:20:10 - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Unicycive Therapeutics, Inc. (UNCY) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Unicycive Therapeutics (UNCY) Stock Analysis Report | Financials & Insights - Benzinga Japan
Portfolio Recap: Is Unicycive Therapeutics Inc stock risky to hold nowEarnings Summary Report & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Unicycive Therapeutics, Inc. (UNCY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Unicycive Therapeutics (UNCY) to Release Quarterly Earnings on Monday - marketbeat.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Unicycive Therapeutics, Inc. (UNCY) And Encourages Investors to Connect - ACCESS Newswire
Pullback Watch: Is Unicycive Therapeutics Inc a potential multi baggerQuarterly Earnings Report & Risk Managed Trade Strategies - baoquankhu1.vn
Stop Loss: Why is Unicycive Therapeutics Inc stock going down2026 Price Action Summary & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
If You Invested $1,000 in Unicycive Therapeutics Inc (UNCY) - Stock Titan
Unicycive Therapeutics Company Profile & Introduction - Moomoo
UNCY Technical Analysis & Stock Price Forecast - Intellectia AI
Important Notice to Long-Term Shareholders of ASP Isotopes - GlobeNewswire
Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR): Soleno Therapeutics, Inc. (NASDAQ: SLNO); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims on Your Behalf - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Unicycive Therapeutics, Inc. (UNCY) And Encourages Stockholders to Reach Out - ACCESS Newswire
Notice to Long-Term Shareholders of ASP Isotopes Inc. - GlobeNewswire
Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Unicycive Therapeutics, Inc. (UNCY) And Encourages Stockholders to Connect - ACCESS Newswire
Finanzdaten der Unicycive Therapeutics Inc-Aktie (UNCY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):